Medexus Announces Strong Fiscal Year 2025 Results, Including Initial Results from Launch of GRAFAPEX (treosulfan) for Injection in the United States — Comtex06:17 PM ET 06/25/2025 Toronto, Ontario and Chicago, Illinois, Jun 25, 2025 (Newsfile Corp via COMTEX News Network) -- Fiscal year 2025 revenue of $108.3 million, record net income of $2.2 million, operating income of... |
Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2025 Conference Call — Comtex05:01 PM ET 06/17/2025 Toronto, Ontario and Chicago, Illinois, Jun 17, 2025 (Newsfile Corp via COMTEX News Network) -- Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 17, 2025) - Medexus Pharmaceuticals... |